None listed
Conditions
Interventions
Intervention1: Inj.ETOMIDATE 2mg/ml: Inj.Etomidate 0.3mg/kg IV over 1 minute
Intervention2: Inj.PROPOFOL 1% 10mg/ml: Inj.Propofol 2mg/kg IV over 1 minute
Intervention3: NIL: NIl
Intervention4: NIl: NI
Sponsors
Chettinad Hospital and Research InstituteKelambakkamChennai
Eligibility
Inclusion criteria
Inclusion criteria: ASA I & II patients undergoing surgery under general anaesthesia
Exclusion criteria
Exclusion criteria: unwilling patients,allergy to study drug,peripheral vascular disease,pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamic response to study drug,intubation response to study drugTimepoint: 1 minute,3 minute and 5 minutes after injection of study drug | — |
Secondary
| Measure | Time frame |
|---|---|
| depth of anaesthesia,incidence of pain and myoclonusTimepoint: 1 minute after injection of study drug | — |
Countries
India
Contacts
Public ContactArun Kumar
Chettinad Hospital and Research Institute,Kelambakkam
Outcome results
None listed